Dr Luca Santarelli named head of CNS discovery and translational area at Roche
This article was originally published in Scrip
Executive Summary
Roche has named Dr Luca Santarelli head of the central nervous system (CNS) discovery and translational area (DTA). The CNS DTA is one of five disease-focused organisations at Roche and oversees R&D in the field of neurology/neurosciences. Since 2007, Dr Santarelli has been the global head of neuroscience, clinical research and early development. He joined Roche in 2005, and has helped progress five internal and partnered programmes to Phase II development in schizophrenia, Alzheimer's disease, multiple sclerosis, treatment-resistant depression and fragile X, and one schizophrenia trial to late-stage development.